Clinical Trial Details
Braintumor Website

[Information provided by: ClinicalTrials.gov, which provides patients, family members, and members of the public easy and free access to information on clinical studies for a wide range of diseases and conditions.]

NCT02918539 : Registry of Amyloid Positive Patients for Alzheimer's Disease Drug Research Trials
PhaseN/A
AgesMin: 50 Years Max: N/A
Eligibility
Inclusion Criteria:

- Male or female patients ? 50 years of age at the time of consent;

- Patients who have objectively verified cognitive impairment and etiology diagnosed or
suspected to be Alzheimer's disease;

- Patients who are willing to make available to Avid a positive amyloid scan, or if an
amyloid scan is not available, are willing to undergo amyloid scanning via the
Florbetapir F 18 PET Scan Addendum;

- Patients who are willing to be contacted for possible participation in Lilly drug
research trials targeting Alzheimer's disease;

- Patients who give informed consent or have a legally authorized representative (LAR)
to consent for enrollment; and

- Patients who have a partner (informant) who is willing to participate as a source of
information and has at least weekly contact with the patient (contact can be
inperson, via telephone or electronic communication). The informant must have
sufficient contact such that the referring physician feels the informant can provide
meaningful information about the patient.

Exclusion Criteria:

- Patients who have a Mini Mental State Examination (MMSE) score of < 10;

- Patients who have an amyloid-negative PET scan (either a historical scan or scan via
the Florbetapir F 18 PET Scan Addendum);

- Patients who have serious or unstable medical conditions that would exclude
completion of all procedures and data collection for the registry, or would be likely
to preclude participation in a drug research trial;

- Patients who have participated in a clinical trial investigating an anti-amyloid
agent;

- Patients who are currently participating in a clinical trial with an investigational
agent; or

- Patients who, in the opinion of the physician, are otherwise unsuitable for this
registry.
LinksPermanent Link to THIS page: https://virtualtrials.com/nct/display1trial.cfm?nct=NCT02918539      |      Link to official Clinicaltrials.gov listing
Locations



Home | Brain Tumor Guide | FAQs | Find A Treatment
Noteworthy Treatments | News | Virtual Trial | Videos | Novocure Optune® | Newsletter
Donations | Brain Tumor Centers | Survivor Stories | Temodar®
Fundraising For Research | Unsubscribe | Contact Us

Copyright (c) 1993 - 2018 by:
The Musella Foundation For Brain Tumor Research & Information, Inc
1100 Peninsula Blvd
Hewlett, NY 11557
888-295-4740